PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32389830-13	2020	Additionally, metformin could affect the interactions of ZO-1 with p-Src/Cx43 via decrease the abnormal cAMP level after pacing (84.04 +- 4.58 vs. 69.34 +- 4.5 nmol/L, P<0.001).	Metformin	14-23	SRC proto-oncogene, non-receptor tyrosine kinase	Canis lupus familiaris	69-72	
32389830-14	2020	CONCLUSIONS: Metformin could alleviate the vulnerability of AF and attenuate the downregulation of gap junction under pacing condition via AMPK pathway and decreasing the P-Src level.	Metformin	13-22	SRC proto-oncogene, non-receptor tyrosine kinase	Canis lupus familiaris	173-176